Skip to main content
Funded Studies

Kevin Loewke, PhD

Co-Founder at Cellogy, Inc.

Chief Executive Officer

Location: Menlo Park, CA United States

Kevin Loewke, PhD, is the co-founder and CEO of Cellogy, a startup focused on stem-cell based modeling of human disease through quantitative imaging and machine learning. Prior to Cellogy, he was co-founder of Auxogyn, a medical device startup in the field of reproductive health. He created and led development of Auxogyn’s flagship product, Eeva, which uses time-lapse imaging and computer vision to predict the viability of pre-implantation human embryos during IVF procedures. His post-doctoral research in embryo development was conducted at the Stanford Institute for Stem Cell Biology, profiled as a top 10 medical breakthrough by Time Magazine, and published in Nature Biotechnology and Nature Communications. He received his PhD from Stanford with a focus on biomedical image analysis.


Associated Grants

  • Measuring LRRK2 Cellular Function in Parkinson’s iPSC-Derived Dopaminergic Neurons

    2013


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.